Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073058 · ClinicalTrials.gov registry record
Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System
A clinical trial, sponsored by Abbott Diabetes Care.
- Completed
- Registry status
- 75
- Enrollment target
NCT02073058 is a clinical trial that has completed, run by Abbott Diabetes Care. The registered enrollment target is 75 participants.
The verdict
NCT02073058 has completed, sponsored by Abbott Diabetes Care.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against Reader capillary Blood Glucose (BG) reference using the Consensus Error Grid. During the course of the wear duration, the subject is required to test fingerstick glucose measurement at least eight (8) times a day for capillary reference glucose measurements and three in-clinic visits of a maximum 13 hours each for venous reference glucose measurements. With every reference measurement, the subject or study staff will perform a measurement on the System.
Interventions
- DEVICE No treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02073058
The ClinicalTrials.gov registry entry for NCT02073058 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment is the first listed.
NCT02073058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02073058 about?
NCT02073058 is a clinical study titled "Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Monitoring System". The purpose of this study is to demonstrate point accuracy of the Abbott Sensor Based Glucose Monitoring (GM) System interstitial glucose results against Reader capillary Blood Glucose (BG) reference using the Consensus Error Grid. During the course of the wear duration, the subject is required to t...
What is the current status of trial NCT02073058?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2014-02. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02073058?
The interventions under investigation include: No treatment (DEVICE).
Who is sponsoring clinical trial NCT02073058?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.